Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?
- PMID: 35798546
- PMCID: PMC9262680
- DOI: 10.3803/EnM.2022.301
Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?
Abstract
Thyroperoxidase antibody (TPOAb) positivity is a well-known risk factor for thyroid dysfunction during pregnancy and is associated with a suboptimal response to thyroidal stimulation by human chorionic gonadotropin. About 75% of TPOAb positive women are euthyroid and there seems to be a higher risk of predominantly miscarriage and preterm birth in this subgroup. Nonetheless, clinical decision making with regards to gestational levothyroxine treatment remains difficult due to a lack of large randomized trials. Future studies assessing dose-dependent associations and additional biomarkers that can distinguish low-risk from high-risk individuals will be key in disentangling the crude clinical data.
Keywords: Pregnancy; Thyroid gland; Thyroperoxidase antibodies.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

References
-
- Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006;107(2 Pt 1):337–41. - PubMed
-
- Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth. Korevaar TI, Derakhshan A, Taylor PN, Meima M, Chen L, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA. 2019;322:632–41. - PMC - PubMed
-
- De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6:575–86. - PubMed
-
- Yehuda M, Wang CH, Pak Y, Chiu KC, Gianoukakis AG. Parity and risk of thyroid autoimmunity based on the NHANES (2001-2002, 2007-2008, 2009-2010, and 2011-2012) J Clin Endocrinol Metab. 2017;102:3437–42. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical